© 1991 Oxford University Press
other |
A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6
GENTEST Corporation 6 Henshaw Street, Woburn, MA 01801, USA
1Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health Bethesda, MD 20892, USA
We have developed a human B-lymphoblastoid cell line, designated 2D6/Hol, which stably expresses human cyto chrome P450 CYP2D6 cDNA. This cell line exhibits bufuralol 11-hydroxylase activity and immunologically detectable CYP2D6 protein. The specific activity of (+)-bufuralol 1'-hydroxylase in microsomes from 2D6/Hol cells was comparable to that observed in human liver microsomes. This cell line was used to examine the mutagemcity activation of three tobacco smoke-derived nitrosamines, N-nltrosonor nicotine (NNN), 1-(N-methyl-N-nitrosamino)-1-(3-pyr-idinyl)-4-butanal) (NNA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), by CYP2D6. Exposure of 2D6/Hol cells to NNK concentrations of 30–90 µg/ml induced a concentration-dependent decrease in relative survival and increase in mutant fraction at the hypoxanthine guanine phosphoribosyl transferase (hprt) locus. In contrast, NNK was non-mutagenic and non-cytotoxic to control cells at exposure concentrations up to 150 µg/ml. NNK mutagenicity in 2D6/Hol cells was compared to the responses observed in isogenic cell lines expressing human CYP1A2 (1A2/Hol), human CYP2A3 (2A3/Hol) and human CYP2E1 (2E1/Hol). These three additional human cytochrome P450-expressing cell lines were also found to be sensitive to NNK-lnduced mutagenicity and cytotoxicity. We found no evidence for CYP2D6-medlated activation of NNN or NNA. NNN was non-cytotoxic and non-mutagenic to both control and 2D6/Hol cells. NNA was equally cytotoxic and mutagenic to control cells and 2D6/Hol cells. The activation of NNA to a mutagen may have been carried out by P450 native to the AHH-1 TK+/– cell line. The 2D6/Hol cell line, In conjunction with the control cell line and other isogenic cell lines expressing other human cytochrome P450 cDNAs provides a useful system for the examination of the role of the polymorphic CYP2D6 in human procarcinogen activation and drug metabolism.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Y. Kim, L. Von Weymarn, O. Larsson, D. Fan, J. M. Underwood, M. S. Peterson, S. S. Hecht, V. A. Polunovsky, and P. B. Bitterman Eukaryotic Initiation Factor 4E Binding Protein Family of Proteins: Sentinels at a Translational Control Checkpoint in Lung Tumor Defense Cancer Res., November 1, 2009; 69(21): 8455 - 8462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Final Report on the Safety Assessment of Capsicum Annuum Extract, Capsicum Annuum Fruit Extract, Capsicum Annuum Resin, Capsicum Annuum Fruit Powder, Capsicum Frutescens Fruit, Capsicum Frutescens Fruit Extract, Capsicum Frutescens Resin, and Capsaicin International Journal of Toxicology, January 1, 2007; 26(1_suppl): 3 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miyazaki, H. Yamazaki, H. Takeuchi, K. Saoo, M. Yokohira, K.-i. Masumura, T. Nohmi, Y. Funae, K. Imaida, and T. Kamataki Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas Carcinogenesis, November 1, 2005; 26(11): 1947 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujieda, H. Yamazaki, T. Saito, K. Kiyotani, M. A. Gyamfi, M. Sakurai, H. Dosaka-Akita, Y. Sawamura, J. Yokota, H. Kunitoh, et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers Carcinogenesis, December 1, 2004; 25(12): 2451 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Alguacil and D. T. Silverman Smokeless and Other Noncigarette Tobacco Use and Pancreatic Cancer: A Case-Control Study Based on Direct Interviews Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 55 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Ulrich, J. Standop, B. M. Schmied, M. B. Schneider, T. A. Lawson, and P. M. Pour Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas Toxicol Pathol, February 1, 2002; 30(2): 247 - 253. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Nakajima, R. Yoshida, N. Shimada, H. Yamazaki, and T. Yokoi Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate Drug Metab. Dispos., August 1, 2001; 29(8): 1110 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vondracek, Z. Xi, P. Larsson, V. Baker, K. Mace, A. Pfeifer, H. Tjalve, M.T. Donato, M.J. Gomez-Lechon, and R. C. Grafstrom Cytochrome P450 expression and related metabolism in human buccal mucosa Carcinogenesis, March 1, 2001; 22(3): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, C. Chen, L. S. Cook, X.-Y. Li, S. Hallagan, M. M. Madeleine, J. R. Daling, and N. S. Weiss Correspondence re: C. Chen et al., CYP2D6 Genotype and the Incidence of Anal and Vulvar Cancer. Cancer Epidemiol. Biomark. Prev., 8: 317-321, 1999 Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 839 - 840. [Full Text]
|
|
|
|
 |
|
 S. S. Hecht Tobacco Smoke Carcinogens and Lung Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Lanza, E. Code, C. L. Crespi, F. J. Gonzalez, and G. S. Yost Specific Dehydrogenation of 3-Methylindole and Epoxidation of Naphthalene by Recombinant Human CYP2F1 Expressed in Lymphoblastoid Cells Drug Metab. Dispos., July 1, 1999; 27(7): 798 - 803. [Abstract] [Full Text]
|
|
|
|
|
|
C. Chen, L. S. Cook, X.-Y. Li, S. Hallagan, M. M. Madeleine, J. R. Daling, and N. S. Weiss CYP2D6 Genotype and the Incidence of Anal and Vulvar Cancer1 Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Meger, E. Richter, W. Zwickenpflug, C. Oehlmann, M. B. Hargaden, Y. I. A-Rahim, and E. S. Vesell Metabolism and Disposition of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Rhesus Monkeys Drug Metab. Dispos., April 1, 1999; 27(4): 471 - 478. [Abstract] [Full Text]
|
|
|
|
|
|
J.-Y. Huan and D. R. Koop Tightly Regulated and Inducible Expression of Rabbit Cyp2e1 Using A Tetracycline-Controlled Expression System Drug Metab. Dispos., April 1, 1999; 27(4): 549 - 554. [Abstract] [Full Text]
|
|
|
|
 |
|
 K.-I. Nunoya, T. Yokoi, K. Kimura, T. Kainuma, K. Satoh, M. Kinoshita, and T. Kamataki A New CYP2A6 Gene Deletion Responsible for the In Vivo Polymorphic Metabolism of (+)-cis-3,5-Dimethyl-2-(3-pyridyl)thiazolidin-4-one Hydrochloride in Humans J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 437 - 442. [Abstract] [Full Text]
|
|
|
|
|
|
M. Lechevrel, A. G. Casson, C. R. Wolf, L. J. Hardie, M. B. Flinterman, R. Montesano, and C. P. Wild Characterization of cytochrome P450 expression in human oesophageal mucosa Carcinogenesis, February 1, 1999; 20(2): 243 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hellmold, T. Rylander, M. Magnusson, E. Reihnér, M. Warner, and J.-A. Gustafsson Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction Mammaplasties J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 886 - 895. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. E. Gram Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity Pharmacol. Rev., December 1, 1997; 49(4): 297 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Messina, R. F. Tyndale, and E. M. Sellers A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1608 - 1614. [Abstract] [Full Text]
|
|
|
|
|
|
E. L. Code, C. L. Crespi, B. W. Penman, F. J. Gonzalez, T. K. H. Chang, and D. J. Waxman Human Cytochrome P4502B6. Interindividual Hepatic Expression, Substrate Specificity, and Role in Procarcinogen Activation Drug Metab. Dispos., August 1, 1997; 25(8): 985 - 993. [Abstract] [Full Text]
|
|
|
|
|
|
L. Chen, J. T. M. Buters, J. P. Hardwick, S. Tamura, B. W. Penman, F. J. Gonzalez, and C. L. Crespi Coexpression of Cytochrome P4502A6 and Human NADPH-P450 Oxidoreductase in the Baculovirus System Drug Metab. Dispos., April 1, 1997; 25(4): 399 - 405. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Kitagawa, N. Kunugita, M. Kitagawa, and T. Kawamoto CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity J. Biol. Chem., May 18, 2001; 276(21): 17830 - 17835. [Abstract] [Full Text] [PDF]
|
|